The KUIC blog focuses on innovation at The University of Kansas. The blog will provide perspectives into the research portfolio at KU and the translation of this research to the market. Track commercialization at KU here.
Polycystic Kidney Disease (PKD) is the most frequently inherited kidney disorder and affects nearly 600,000 Americans and as many as 12 million people worldwide. Currently, there are no FDA approved treatments for PKD.
Researchers at the University of Kansas have created a novel compound and method for treating PKD that leads to the inhibition of cyst growth.